Simplexa COVID-19 Direct

Simplexa COVID-19 Direct is an FDA 510(k)-cleared medical device (K212147) manufactured by Diasorin Molecular, LLC. This device is classified under the Microbiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on September 12, 2022. Regulation: 8.